Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.

Issue 9, 2016
Previous Article Next Article

Recent advances in the rational design and optimization of antibacterial agents

Author affiliations


This review discusses next-generation antibacterial agents developed using rational, or targeted, drug design strategies. The focus of this review is on small-molecule compounds that have been designed to bypass developing bacterial resistance, improve the antibacterial spectrum of activity, and/or to optimize other properties, including physicochemical and pharmacokinetic properties. Agents are discussed that affect known antibacterial targets, such as the bacterial ribosome, nucleic acid binding proteins, and proteins involved in cell-wall biosynthesis; as well as some affecting novel bacterial targets which do not have currently marketed agents. The discussion of the agents focuses on the rational design strategies employed and the synthetic medicinal chemistry and structure-based design techniques utilized by the scientists involved in the discoveries, including such methods as ligand- and structure-based strategies, structure–activity relationship (SAR) expansion strategies, and novel synthetic organic chemistry methods. As such, the discussion is limited to small-molecule therapeutics that have confirmed macromolecular targets and encompasses only a fraction of all antibacterial agents recently approved or in late-stage clinical trials. The antibacterial agents selected have been recently approved for use on the U.S. or European markets or have shown promising results in phase 2 or phase 3 U.S. clinical trials.

Graphical abstract: Recent advances in the rational design and optimization of antibacterial agents

Back to tab navigation

Publication details

The article was received on 26 Apr 2016, accepted on 05 Jul 2016 and first published on 07 Jul 2016

Article type: Review Article
DOI: 10.1039/C6MD00232C
Author version
Download author version (PDF)
Citation: Med. Chem. Commun., 2016,7, 1694-1715

  •   Request permissions

    Recent advances in the rational design and optimization of antibacterial agents

    J. A. Jones, K. G. Virga, G. Gumina and K. E. Hevener, Med. Chem. Commun., 2016, 7, 1694
    DOI: 10.1039/C6MD00232C

Search articles by author